NO842821L - Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinon-derivater - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinon-derivater

Info

Publication number
NO842821L
NO842821L NO842821A NO842821A NO842821L NO 842821 L NO842821 L NO 842821L NO 842821 A NO842821 A NO 842821A NO 842821 A NO842821 A NO 842821A NO 842821 L NO842821 L NO 842821L
Authority
NO
Norway
Prior art keywords
pyrrolidinon
derivatives
procedure
preparation
therapeutic active
Prior art date
Application number
NO842821A
Other languages
English (en)
Other versions
NO163617B (no
NO163617C (no
Inventor
Kathleen Biziere
Jean-Pierre Chambon
Jean-Charles Molimard
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO842821L publication Critical patent/NO842821L/no
Publication of NO163617B publication Critical patent/NO163617B/no
Publication of NO163617C publication Critical patent/NO163617C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/50Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C205/51Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/6533Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO842821A 1983-07-12 1984-07-11 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinon-derivater. NO163617C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8311636A FR2549053B1 (fr) 1983-07-12 1983-07-12 Nouveaux derives de la pyrrolidine actifs sur le systeme nerveux central, leur procede de preparation, les medicaments en contenant

Publications (3)

Publication Number Publication Date
NO842821L true NO842821L (no) 1985-01-14
NO163617B NO163617B (no) 1990-03-19
NO163617C NO163617C (no) 1990-06-27

Family

ID=9290775

Family Applications (1)

Application Number Title Priority Date Filing Date
NO842821A NO163617C (no) 1983-07-12 1984-07-11 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinon-derivater.

Country Status (23)

Country Link
US (1) US4604383A (no)
EP (1) EP0135406B1 (no)
JP (1) JPS6084265A (no)
KR (1) KR910003362B1 (no)
AR (1) AR240451A1 (no)
AT (1) ATE30150T1 (no)
AU (1) AU560725B2 (no)
CA (1) CA1249593A (no)
DD (2) DD229121A5 (no)
DE (1) DE3466686D1 (no)
DK (1) DK343784A (no)
ES (1) ES534221A0 (no)
FI (1) FI77848C (no)
FR (1) FR2549053B1 (no)
GR (1) GR81502B (no)
HU (1) HU192564B (no)
IL (1) IL72324A (no)
NO (1) NO163617C (no)
NZ (1) NZ208865A (no)
PT (1) PT78874B (no)
SU (1) SU1391497A3 (no)
YU (2) YU121384A (no)
ZA (1) ZA845397B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
ES2043943T3 (es) * 1988-05-20 1994-01-01 Zambon Spa Procedimiento para la preparacion de compuestos con actividad analgesica central.
GB9307431D0 (en) * 1993-04-08 1993-06-02 Oxford Asymmetry Ltd Improvements in or relating to chiral auxiliaries
CN106977415B (zh) * 2016-01-15 2021-03-26 广东东阳光药业有限公司 一种沙库必曲的中间体及其制备方法
CN109071407A (zh) 2016-02-29 2018-12-21 广东东阳光药业有限公司 一种沙库必曲的中间体及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3272842A (en) * 1965-06-25 1966-09-13 Lilly Co Eli Novel pyrrolinones
AU518986B2 (en) * 1977-10-11 1981-10-29 Takeda Chemical Industries Ltd. Lactams
FR2436779A1 (fr) * 1978-09-22 1980-04-18 Pharmindustrie Derives de pyrrolidine-2 methanol utilisables comme medicaments

Also Published As

Publication number Publication date
NO163617B (no) 1990-03-19
US4604383A (en) 1986-08-05
EP0135406A1 (fr) 1985-03-27
DE3466686D1 (en) 1987-11-12
YU81086A (en) 1986-10-31
NZ208865A (en) 1986-12-05
ATE30150T1 (de) 1987-10-15
KR850001165A (ko) 1985-03-16
PT78874B (fr) 1986-06-02
IL72324A (en) 1987-10-30
AU3021684A (en) 1985-01-17
HU192564B (en) 1987-06-29
FR2549053B1 (fr) 1985-12-27
GR81502B (no) 1984-12-11
SU1391497A3 (ru) 1988-04-23
FI842795A0 (fi) 1984-07-11
AR240451A1 (es) 1990-04-30
ZA845397B (en) 1985-02-27
KR910003362B1 (ko) 1991-05-28
DK343784D0 (da) 1984-07-12
IL72324A0 (en) 1984-11-30
ES8504122A1 (es) 1985-04-16
FR2549053A1 (fr) 1985-01-18
FI77848B (fi) 1989-01-31
FI842795A (fi) 1985-01-13
AU560725B2 (en) 1987-04-16
DK343784A (da) 1985-01-13
EP0135406B1 (fr) 1987-10-07
FI77848C (fi) 1989-05-10
JPS6084265A (ja) 1985-05-13
YU121384A (en) 1986-10-31
DD229121A5 (de) 1985-10-30
HUT34443A (en) 1985-03-28
ES534221A0 (es) 1985-04-16
NO163617C (no) 1990-06-27
CA1249593A (en) 1989-01-31
DD227962A5 (de) 1985-10-02
PT78874A (fr) 1984-08-01

Similar Documents

Publication Publication Date Title
NO841568L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenetanolamin-derivater
NO843979L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO168770C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO820479L (no) Fremgangsmaate for fremstilling av terapeutisk aktive carbostyrilderivater
NO170629C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO845176L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 4h-3,1-benzoksazin-4-on-derivater
NO168355C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO167026C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO843084L (no) Fremgangsmaate for fremstilling av terapeutisk aktive adenosin-derivater
NO841542L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO854369L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzimidazol-derivater
NO843042L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kumarin-derivater
NO168299C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater
NO171592C (no) Fremgangsmaate for fremstilling av aktive cinnolin-derivater
NO840212L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyre-derivater
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO169069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater
NO833527L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklobutylderivater
NO820112L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater
NO843377L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater
NO813263L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater